New evidence for presence of tyrosinase in substantia nigra, forebrain and midbrain

被引:96
|
作者
Tief, K [1 ]
Schmidt, A [1 ]
Beermann, F [1 ]
机构
[1] Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland
来源
MOLECULAR BRAIN RESEARCH | 1998年 / 53卷 / 1-2期
关键词
brain; beta-galactosidase; substantia nigra; transgenic mouse; tyrosinase; neuromelanin;
D O I
10.1016/S0169-328X(97)00301-X
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Tyrosinase and tyrosinase-related proteins (TRP-1 and TRP-2) are essential for melanin synthesis and are expressed in neural crest-derived melanocytes and in the pigment epithelium of the retina. Recent results suggest expression of all three proteins within the central nervous system. We performed a transgenic assay using beta-galactosidase as reporter gene to monitor tyrosinase promoter activity in vivo. During embryogenesis, we found expression in several locations of developing forebrain and midbrain. Tyrosinase, TRP-1 and TRP-2 had been equally found in extracts of adult mouse brain. In adult brain, we detected tyrosinase promoter activity in cortex, olfactory system, hippocampus, epithalamus and substantia nigra, areas corresponding to positive staining during embryogenesis. Thus, tyrosinase promoter is active throughout murine brain development, and tyrosinase could be implicated in neuromelanin formation in the substantia nigra, and in neurodegenerative disorders like Parkinson's disease. (C) 1998 Elsevier Science B.V.
引用
收藏
页码:307 / 310
页数:4
相关论文
共 50 条
  • [31] EVIDENCE IMPLICATING SUBSTANTIA NIGRA IN REGULATION OF KINDLED SEIZURE THRESHOLD
    MCNAMARA, JO
    GALLOWAY, MT
    RIGSBEE, LC
    SHIN, C
    JOURNAL OF NEUROSCIENCE, 1984, 4 (09): : 2410 - 2417
  • [32] INVIVO EVIDENCE FOR A DENDRITIC RELEASE OF DOPAMINE IN THE CAT SUBSTANTIA NIGRA
    CHERAMY, A
    NIEOULLON, A
    GLOWINSKI, J
    APPLIED NEUROPHYSIOLOGY, 1979, 42 (1-2) : 57 - 59
  • [33] GLUTAMATE RECEPTORS IN STRIATUM AND SUBSTANTIA-NIGRA - EFFECTS OF MEDIAL FOREBRAIN-BUNDLE LESIONS
    WULLNER, U
    TESTA, CM
    CATANIA, MV
    YOUNG, AB
    PENNEY, JB
    BRAIN RESEARCH, 1994, 645 (1-2) : 98 - 102
  • [34] Temporal and sequential analysis of microglia in the substantia nigra following medial forebrain bundle axotomy in rat
    Sugama, S
    Cho, BP
    Degiorgio, LA
    Shimizu, Y
    Kim, SS
    Kim, YS
    Shin, DH
    Volpe, BT
    Reis, DJ
    Cho, S
    Joh, TH
    NEUROSCIENCE, 2003, 116 (04) : 925 - 933
  • [35] LOCALIZATION OF OPIATE RECEPTORS IN SUBSTANTIA NIGRA EVIDENCE BY LESION STUDIES
    LLORENSCORTES, C
    POLLARD, H
    SCHWARTZ, JC
    NEUROSCIENCE LETTERS, 1979, 12 (2-3) : 165 - 170
  • [36] Is levodopa toxic to nondegenerating substantia nigra cells? Clinical evidence
    Rajput, AH
    Fenton, ME
    Dhand, A
    NEUROLOGY, 1996, 46 (02) : 5110 - 5110
  • [37] No evidence of substantia nigra telomere shortening in Parkinson's disease
    Hudson, Gavin
    Faini, David
    Stutt, Andrea
    Eccles, Martin
    Robinson, Louise
    Burn, David J.
    Chinnery, Patrick F.
    NEUROBIOLOGY OF AGING, 2011, 32 (11) : 2107.e3 - 2107.e5
  • [38] REPETITIVE TRANSIENT FOREBRAIN ISCHEMIA IN GERBILS - DELAYED NEURONAL DAMAGE IN THE SUBSTANTIA-NIGRA RETICULATA
    SHUAIB, A
    IJAZ, S
    KALRA, J
    CODE, W
    BRAIN RESEARCH, 1992, 574 (1-2) : 120 - 124
  • [39] EVIDENCE THAT SUBSTANTIA NIGRA IS CRUCIAL TO NEURAL NETWORK OF KINDLED SEIZURES
    MCNAMARA, JO
    RIGSBEE, LC
    GALLOWAY, MT
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1983, 86 (3-4) : 485 - 486
  • [40] Smoking and Substantia Nigra Neuron Density in the Presence and Absence of Lewy Pathology
    Ross, G.
    Abbott, R.
    Petrovitch, H.
    Duda, J.
    Uyehara-Lock, J.
    Masaki, K.
    Tanner, C.
    MOVEMENT DISORDERS, 2022, 37 : S527 - S527